Device Trial Radar · NCT05490459
Jewel Electrophysiology (EP) Lab Study
Last checked: Nov 19, 2026Latest source record: Apr 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
18
Actual
Start
Nov 27, 2018
Primary completion
Oct 7, 2021
Study completion Apr 17, 2024
Sponsor
- Lead sponsor
- Element Science, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 5, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Single arm open label evaluation of the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) defibrillation waveform in adult cardiac patients.
Conditions
- Sudden Cardiac Arrest
Interventions
Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)Device
Automatic external cardioverter defibrillator that monitors patients at risk for SCA and provides a therapeutic shock if needed.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Effectiveness of the JewelTime frame: Immediately following defibrillation with the study device.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nemocnice Na Homolce Hospital
Prague, Czechia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.